Intake ofStJohn's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone
- 20 January 2015
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 79 (2) , 298-306
Abstract
Aims: Our objective was to investigate the steady‐state pharmacokinetic and pharmacodynamic interaction between the antidepressive herbal medicineStJohn's wort and the antidiabetic drug metformin.Methods: We performed an open cross‐over study in 20 healthy male subjects, who received 1 g of metformin twice daily for 1 week with and without 21 days of preceding and concomitant treatment withStJohn's wort. The pharmacokinetics of metformin was determined, and a 2 h oral glucose tolerance test was performed.Results: StJohn's wort decreased the renal clearance of metformin but did not affect any other metformin pharmacokinetic parameter. The addition ofStJohn's wort decreased the area under the glucose concentration–time curve [702 (95% confidence interval, 643–761)vs. 629 min*mmol/L (95% confidence interval, 568–690),P= 0.003], and this effect was caused by a statistically significant increase in the acute insulin response.Conclusions: StJohn's wort improves glucose tolerance by enhancing insulin secretion independently of insulin sensitivity in healthy male subjects taking metformin.Keywords
Funding Information
- The Psychiatric Research Council of Southern Denmark
This publication has 40 references indexed in Scilit:
- Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adultsCurrent Opinion in Psychiatry, 2013
- Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 geneBiochemical Pharmacology, 2011
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 2011
- Bidirectional Association Between Depression and Type 2 Diabetes Mellitus in WomenArchives of internal medicine (1960), 2010
- Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metforminPharmacogenetics and Genomics, 2010
- Double‐transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cationsBritish Journal of Pharmacology, 2010
- Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†Hepatology, 2009
- Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin PharmacokineticsClinical Pharmacology & Therapeutics, 2007
- Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionJournal of Clinical Investigation, 2007
- Pharmacokinetic Interactions of Drugs with St John’s WortJournal of Psychopharmacology, 2004